The gold-standard GLP-1 for medical weight loss Pricing varies by protocol The most widely studied GLP-1 receptor agonist for weight management, administered as a simple once-weekly subcutaneous injection
Hypertension, tachycardia
In this blog post, we will delve into what peptide therapy is, how it works, its potential benefits, and how it can be incorporated into your wellness plan
Article 6 mins Use These 5 Tips to Build a Compelling ESG Story in Todays Evolving D&O Market ESG ratings dont always tell the whole story, which is why companies should develop a clear and compelling ESG story for D&O underwriters
In patients with type 2 diabetes (T2D), oral semaglutide matches sodiumglucose cotransporter 2 (SGLT2) inhibitors for blood sugar and weight reduction while better preserving skeletal muscle mass, as deciphered from the outcomes of a study published in "Journal of Diabetes Investigation"
The ability of semaglutide, a GLP-1 receptor agonist, to reduce heavy drinking in individuals with obesity and alcohol use disorder adds to the growing literature on gut-brain axis modulation of addictive behaviors